Research · Repigmentation pathways · 6 min read

Vitiligo Myths And Facts

Vitiligo is treatable, not contagious — and outcomes have improved meaningfully in the last decade.

Reviewed by Clinical Dermatology ReviewMD Dermatology · IADVL membersUpdated

Your decision stage

  1. 01Research
  2. 02Comparison
  3. 03Evaluation
  4. 04Decision
  5. 05Ready

Decision tool · 4 min

Vitiligo Treatment Explorer

If this article is the right read for where you are, the Vitiligo Treatment Explorer is the right next step. Identify your disease activity, candidacy and the right treatment sequence.

Begin the tool →

Quick answer

Vitiligo is an autoimmune condition affecting melanocytes. It is not contagious, not caused by diet, and not the result of stress alone. Modern combination therapy achieves meaningful repigmentation in most patients — especially when started early and sustained.

Key takeaways

  • 01Autoimmune, not contagious
  • 02Treatable; not curable
  • 03Earlier intervention produces stronger outcomes
  • 04JAK inhibitors have changed outcomes for select patients

Common myths

  • 01'It's caused by eating fish with milk' — no
  • 02'It spreads by touch' — no
  • 03'There is no treatment' — false; multiple effective pathways exist
  • 04'Surgery is the only option' — surgery is one option, for stable disease only

Decision tool · 4 min

Vitiligo Treatment Explorer

Identify your disease activity, candidacy and the right treatment sequence.

Begin the tool →

FAQs

Asked often.

Is vitiligo hereditary?

+

There is a genetic component — first-degree relatives have higher risk — but most patients have no family history.

What's commonly misunderstood

Patient misconceptions, clarified.

  • 01That vitiligo is untreatable — combination therapy achieves meaningful repigmentation in most patients
  • 02That diet 'causes' or 'cures' vitiligo — there's no robust evidence for food triggers
  • 03That depigmentation is permanent everywhere — facial patches in particular often respond well to treatment

What patients get wrong

Common mistakes to avoid

  • 01Waiting years before starting treatment — early disease responds best
  • 02Chasing single-modality fixes when combination therapy is the evidence-based norm
  • 03Trying surgery while disease is still active
  • 04Discontinuing phototherapy after weeks — response takes months

Questions patients forget to ask

The questions that protect your outcome.

  • 01Is my disease active or stable, and how is that being assessed?
  • 02Which combination of topicals + phototherapy fits my pattern and time?
  • 03What's the realistic timeline before I judge whether this is working?
  • 04Where does surgery fit, if at all, in my long-term plan?

Decision checklist

Before you commit, verify every one.

  • Disease activity formally assessed before starting any plan
  • Combination plan (topicals + phototherapy) prepared, not single-modality
  • Realistic 6-month and 12-month review milestones agreed
  • Sun-protection and camouflage options discussed

During your consultation

What to actually discuss.

  • 01Whether your disease is active or stable today
  • 02Combination treatment tailored to your sites and skin type
  • 03Realistic timelines — by month 3, 6 and 12
  • 04Mental-health and lifestyle support alongside treatment

The decision arc

  1. 01

    Research

    Understand what the category contains and which paths exist.

  2. 02

    Comparison

    Weigh approaches side-by-side and rule out the wrong-fit paths.

  3. 03

    Evaluation

    Confirm candidacy and pressure-test your shortlist.

  4. 04

    Decision

    Prepare specific questions and de-risk the final commitment.

Personalized Guidance

Where are you in the decision?

AltisPath places you on the arc from exploration to consultation-ready — so the next step is the right one, not just the next available one.

Take the assessment →

Decision tool · 4 min

Vitiligo Treatment Explorer

Decision tools are the primary way patients turn insight into a plan on AltisPath. The Vitiligo Treatment Explorer produces a personalised report you can take to any provider — privately, before contact.

Begin the tool →

Continue your journey

The next step, recommended.

Explore your treatment path

Insight is the beginning. A plan is the point.

Move from reading to a personalized report and tailored next steps — privately, on your own time.

Editorial standards

Dermatology content is reviewed by board-certified dermatologists practicing in Pune, Mumbai or Bengaluru.

  1. 01Drafted by the AltisPath decision-content team
  2. 02Reviewed by a practicing clinician in the relevant specialty
  3. 03Cross-checked against current Indian clinical practice
  4. 04Updated when guidelines or pricing change materially

Medical disclaimer: AltisPath is a treatment decision and guidance platform. This article is educational and is not a substitute for a personal medical consultation. Treatment decisions should be made with a qualified clinician who has reviewed your individual case.